TGFBR1 and systemic sclerosis: Although there was some variation between the three primary SSc cell lines, there was a profound decrease in Col‐1 and αSMA (of between 60% and 80%) in the presence of BB7, a pan‐TGF‐β blocking antibody or the ALK5 inhibitor.